Magnetic resonance spectroscopy for evaluation of suspected brain tumor

TEC Bull (Online). 2003 Mar 13;20(1):23-6.
No abstract available

MeSH terms

  • Blue Cross Blue Shield Insurance Plans
  • Brain Neoplasms / diagnosis*
  • Device Approval
  • Drug Approval
  • Evidence-Based Medicine
  • Humans
  • Insurance Coverage
  • Magnetic Resonance Spectroscopy*
  • Outcome Assessment, Health Care
  • Protons
  • Technology Assessment, Biomedical*
  • United States
  • United States Food and Drug Administration

Substances

  • Protons